VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST ON THE VERIGENE SP SYSTEM (RVNATSP)

Respiratory Virus Panel Nucleic Acid Assay System

NANOSPHERE, INC

The following data is part of a premarket notification filed by Nanosphere, Inc with the FDA for Verigene Respiratory Virus Nucleic Acid Test On The Verigene Sp System (rvnatsp).

Pre-market Notification Details

Device IDK092566
510k NumberK092566
Device Name:VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST ON THE VERIGENE SP SYSTEM (RVNATSP)
ClassificationRespiratory Virus Panel Nucleic Acid Assay System
Applicant NANOSPHERE, INC 4088 COMMERCIAL AVENUE Northbrook,  IL  60062
ContactGregory W Shipp
CorrespondentGregory W Shipp
NANOSPHERE, INC 4088 COMMERCIAL AVENUE Northbrook,  IL  60062
Product CodeOCC  
CFR Regulation Number866.3980 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2009-08-20
Decision Date2009-10-09
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00857573006409 K092566 000
00857573006010 K092566 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.